ENDRA Life Sciences Secures Patent for Innovative TAEUS® Temperature Monitoring in Surgery

ENDRA Life Sciences Secures Key Patent for Minimally Invasive Thermal Procedures

ENDRA Life Sciences Inc. has recently been awarded a significant patent by the European Patent Office, enhancing its portfolio in the realm of Thermo Acoustic Enhanced UltraSound (TAEUS®) technology. The patent, EP4247282, outlines innovative methods for monitoring tissue temperature in minimally invasive thermal surgical procedures. This development aligns seamlessly with ENDRA's existing U.S. patent, US11,051,883, and aims to facilitate the integration of temperature monitoring with current ablation systems, which are critical in various medical applications. As minimally invasive techniques gain traction due to their advantages, including reduced pain and quicker recovery times, this patent positions ENDRA at the forefront of advancing surgical technology.

The patent underscores ENDRA’s commitment to addressing unmet clinical needs through innovative technology. ENDRA's CEO, Alexander Tokman, highlights the importance of this patent as the company strives to enhance its hybrid ultrasound and thermoacoustic imaging systems. This advancement not only broadens the applications of the TAEUS® platform but also reinforces ENDRA's strategy of creating valuable solutions within the medical field. With a total of 82 patents worldwide, including 17 in Europe, ENDRA demonstrates a robust commitment to intellectual property protection, which is essential for maintaining a competitive edge in key markets such as the U.S., Europe, and China.

The TAEUS® technology aims to provide affordable, MRI-like tissue characterization directly at the point of care, with an initial focus on non-invasive assessment of fatty liver disease—a condition that affects over two billion people globally and is in desperate need of effective diagnostic tools. ENDRA is also exploring additional clinical applications for TAEUS®, including the visualization of tissue temperature during energy-based surgical interventions, which could revolutionize how temperature monitoring is approached in surgical settings.

In addition to its recent patent achievement, ENDRA Life Sciences continues to engage with the medical community to promote the practical applications of its technology. The company encourages interested parties to learn more about its innovative solutions by visiting its website. The advancements in TAEUS® technology highlight ENDRA's dedication to improving patient outcomes through cutting-edge medical technology.